<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Singh G</submitter><funding>Science and Engineering Research Board</funding><pagination>2826-2854</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11324062</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(8)</volume><pubmed_abstract>Twelve 3,5-disubstituted-thiazolidine-2,4-dione (TZD) hybrids were synthesized using solution phase chemistry. Continuing our previous work, nine &lt;i>O&lt;/i>-modified ethyl vanillin (8a-i) derivatives were synthesized and reacted with the TZD core &lt;i>via&lt;/i> Knoevenagel condensation under primary reaction conditions to obtain final derivatives 9a-i. Additionally, three isatin-TZD hybrids (11a-c) were synthesized. The intermediates and final derivatives were characterized using &lt;sup>1&lt;/sup>H and &lt;sup>13&lt;/sup>C NMR spectroscopy, and the observed chemical shifts agreed with the proposed structures. The &lt;i>in vitro&lt;/i> alpha-amylase and alpha-glucosidase inhibitory evaluation of newly synthesized derivatives revealed compounds 9F and 9G as the best dual inhibitors, with IC&lt;sub>50&lt;/sub> values of </pubmed_abstract><journal>RSC medicinal chemistry</journal><pubmed_title>Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, &amp;lt;i&amp;gt;in vitro&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;in vivo&amp;lt;/i&amp;gt; anti-diabetic evaluation.</pubmed_title><pmcid>PMC11324062</pmcid><funding_grant_id>CRG/2021/001009</funding_grant_id><pubmed_authors>Singh G</pubmed_authors><pubmed_authors>Mehan S</pubmed_authors><pubmed_authors>Monga V</pubmed_authors><pubmed_authors>Singh R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, &amp;lt;i&amp;gt;in vitro&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;in vivo&amp;lt;/i&amp;gt; anti-diabetic evaluation.</name><description>Twelve 3,5-disubstituted-thiazolidine-2,4-dione (TZD) hybrids were synthesized using solution phase chemistry. Continuing our previous work, nine &lt;i>O&lt;/i>-modified ethyl vanillin (8a-i) derivatives were synthesized and reacted with the TZD core &lt;i>via&lt;/i> Knoevenagel condensation under primary reaction conditions to obtain final derivatives 9a-i. Additionally, three isatin-TZD hybrids (11a-c) were synthesized. The intermediates and final derivatives were characterized using &lt;sup>1&lt;/sup>H and &lt;sup>13&lt;/sup>C NMR spectroscopy, and the observed chemical shifts agreed with the proposed structures. The &lt;i>in vitro&lt;/i> alpha-amylase and alpha-glucosidase inhibitory evaluation of newly synthesized derivatives revealed compounds 9F and 9G as the best dual inhibitors, with IC&lt;sub>50&lt;/sub> values of </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-03-27T15:51:00.118Z</modification><creation>2025-08-24T03:08:48.901Z</creation></dates><accession>S-EPMC11324062</accession><cross_references><pubmed>39149094</pubmed><doi>10.1039/d4md00199k</doi></cross_references></HashMap>